Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
about
Unveiling changes in the landscape of patient populations in cancer early drug developmentCancer prevention research - then and nowWhat are the endpoints of therapy for acute leukemias? Old definitions and new challenges.Signal transduction molecules as targets for cancer prevention.Implementation of validated pharmacodynamic assays in multiple laboratories: challenges, successes, and limitations.Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer TherapiesA novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.Phase 0 clinical trials in oncology new drug development.Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck.Report of the EORTC-PAMM Meeting, Brussels, 16-18 March 2009: new strategies for a targeted and personalised therapy of cancer.Combining targeted therapies: practical issues to consider at the bench and bedside.Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva.New considerations in the design of clinical trials for the treatment of acute leukemia.Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissues.Microfluidic cell arrays in tumor analysis: new prospects for integrated cytomics.Microdosing in early lead discovery.Circulating tumor cells, enumeration and beyond.Translational research in oncology--10 years of progress and future prospects.Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development.Role of Phase 0 trials in drug development.Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.
P2860
Q28073826-07D274F9-3D85-438D-8C4B-4150528A6AB5Q33726196-D1B32A6B-7437-4FAD-9201-F6FFF56A3EB5Q33775647-A931D89F-00CC-447F-B998-3C681CCF93D0Q33828052-833184BE-B7B2-4A0B-B759-75A59DB81C04Q33897223-D880208A-7387-4B9C-BD3B-2FCC3D0F026FQ33985780-EE699052-573F-4190-A3FD-D5543CABFD85Q34289862-1F24C698-3C53-488A-9D22-1323C4AC094AQ34941964-1350223D-2FAC-495C-AE38-65FC397C5481Q35287729-9E343B4F-BA79-4E63-AECE-8D35B133BFC6Q35572921-5F5B8CEC-1FD8-407E-AABD-A16E87B66B4EQ35583672-8B8BAF42-82F7-43C7-A872-18E9FB9B7659Q35602195-9A7D3E2B-A83A-4031-8506-90ADF1923ED7Q36641721-343BE191-2FAD-45EB-9BF5-4BBAC8C31E4CQ36737058-F0F8856C-D71D-4730-B0CA-B9BCECE916C1Q37750876-F294846C-8209-423E-AE77-E20C4A83E8B3Q37810233-7717A935-791A-4F4B-933C-61B34D245A56Q38166574-CF8A5953-7CDE-4ED0-9EF0-2417B4642050Q38257126-C5EF7943-7B6F-4C85-BAB0-973216D2AAD8Q38818203-C15F620F-C381-427F-84E2-40BB995E7D3AQ39934032-B0042BBF-2345-4910-B83D-9BBE701A70F4Q45058787-5E49CD4F-C5AC-434B-9D06-083B144E1481Q45929421-511EF43D-6901-441A-9811-0CDD6DDE808DQ47385759-838195B3-DABE-4E30-803A-797A192E8FA5
P2860
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@ast
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@en
type
label
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@ast
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@en
prefLabel
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@ast
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@en
P2860
P1476
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
@en
P2093
James H Doroshow
Ralph E Parchment
P2860
P304
P356
10.1158/1078-0432.CCR-07-4562
P407
P577
2008-06-01T00:00:00Z